Eric Miller (@ericmillermdphd) 's Twitter Profile
Eric Miller

@ericmillermdphd

GI Radiation Oncologist at Ohio State University Comprehensive Cancer Center

ID: 1579863540642578433

calendar_today11-10-2022 15:57:05

83 Tweet

247 Followers

237 Following

#CRCTrialsChat (@crctrialschat) 's Twitter Profile Photo

For the next #CRCTrialsChat #VideoShorts on Monday, May 20th at 7:00 PM CT, we will have Drs @ Kate Hitchcock (she/ella), Eric Miller & Paul Romesser talk to us about their #TotalAblativeTherapy trial ERASur šŸ”„for metastatic #colorectalcancer! See you then! #ClinicalTrialsDay #CRCSM

For the next #CRCTrialsChat #VideoShorts on Monday, May 20th at 7:00 PM CT, we will have Drs @ <a href="/hitchcock_kate/">Kate Hitchcock (she/ella)</a>, <a href="/EricMillerMDPhD/">Eric Miller</a> &amp; <a href="/DrPaulRomesser/">Paul Romesser</a> talk to us about their #TotalAblativeTherapy trial ERASur šŸ”„for metastatic #colorectalcancer! See you then!
#ClinicalTrialsDay
#CRCSM
#CRCTrialsChat (@crctrialschat) 's Twitter Profile Photo

This #ClinicalTrialsDay, please join #CRCTrialsChat for this month's #VideoShorts on #ERASur! Watch the PIs, Kate Hitchcock (she/ella) Eric Miller & Paul Romesser talk about their #clinicaltrial & how it maybe relevant to you.. Join us at 7:00 PM CT tonight! #CRCSM #colorectalcancer

Manju George MVSc PhD Rectal Cancer Survivor (@manjuggm) 's Twitter Profile Photo

Dr. Nina Niu Sanford #CRCTrialsChat Great points! I hope #ERASur can be opened in many more places. It’s a very patient-centric trial & can lead to practice-changing information. In my mind, by splitting mCRC into multiple small chunks & advancing tx for each maybe a good way to improve outcomes. #CRCTrialsChat

Pashtoon Kasi MD, MS (@pashtoonkasi) 's Twitter Profile Photo

#ASCO24 ASCO Interesting to see that additional use of local therapies to chase ā€œoligoā€ metastases in more extensive metastatic #colorectalcancer didn’t add much to survival. šŸ”Œ for ongoing Alliance for Clinical Trials in Oncology ERASUR study. ā€œMulti-organā€ definitions are very different. OncoAlert

#ASCO24 <a href="/ASCO/">ASCO</a>

Interesting to see that additional use of local therapies to chase ā€œoligoā€ metastases in more extensive metastatic #colorectalcancer didn’t add much to survival.

šŸ”Œ for ongoing <a href="/ALLIANCE_org/">Alliance for Clinical Trials in Oncology</a> ERASUR study. ā€œMulti-organā€ definitions are very different.

<a href="/OncoAlert/">OncoAlert</a>
Eric Miller (@ericmillermdphd) 's Twitter Profile Photo

An important study, but about 1/3 of patients with peritoneal disease. We need more prospective data to better counsel our patients, including completion of #ERASur clinicaltrials.gov/study/NCT05673… Kate Hitchcock (she/ella) Paul Romesser Sepideh Gholami, MD, MAS, FACS, FSSO COLONTOWN

Betsy Post (@betsypost2) 's Twitter Profile Photo

šŸ“Œ Save the Date for our next DocTalk šŸ‘Øā€āš•ļøā€” July 10th at 7pm EDT on Zoom — I am thrilled to host Eric Miller to discuss #SBRT for #CRC Liver and Lung Mets. (We will also discuss the ERASur trial.) Our patients in COLONTOWN can’t wait for this one! šŸ’™ #crcsm

šŸ“Œ Save the Date for our next DocTalk šŸ‘Øā€āš•ļøā€” July 10th at 7pm EDT on Zoom — I am thrilled to host <a href="/EricMillerMDPhD/">Eric Miller</a> to discuss #SBRT for #CRC Liver and Lung Mets. (We will also discuss the ERASur trial.) Our patients in <a href="/colontown/">COLONTOWN</a> can’t wait for this one! šŸ’™ #crcsm
Neil Newman (@nbn426) 's Twitter Profile Photo

#SALCS 2024 tumor board on challenging HCC cases. Lauren Henke, MD, MSCI is crushing it explaining not only the data for SBRT but also the vast array of tools we have at our disposal (cbct, lipodol, fiducials, adaptive , motion management, beam control ) to ensure safe and highly

#SALCS 2024 tumor board on challenging HCC cases. <a href="/lauren_henke/">Lauren Henke, MD, MSCI</a> is crushing it explaining not only the data for SBRT but also the vast array of tools we have at our disposal (cbct, lipodol, fiducials, adaptive , motion management, beam control ) to ensure safe and highly
Lauren Henke, MD, MSCI (@lauren_henke) 's Twitter Profile Photo

Great to be in San Antonio representing the RO team and highlighting the growing data for SBRT/hypofrac RT šŸ’„for HCC, Cholangio, and metastatic liver disease with Eric Miller Neil Newman and Eugene J. Koay, MD, PhD at #SALCS šŸ’« thanks for the invite!! RadOncUH MD Anderson Cancer Center

Michael Chuong (@mikechuongmd) 's Twitter Profile Photo

This month's IJROBP - The Red Journal Oncology Scan features commentary on several impactful GI trials by Eric Miller Dr. Nina Niu Sanford Hyun Kim Krishan Jethwa Andrzej Jon Ashman Maria Hawkins ā˜‘ļøESOPEC ā˜‘ļøRTOG 1112 ā˜‘ļøABC-07 ā˜‘ļøCROSSFIRE ā˜‘ļøRTOG 0848 authors.elsevier.com/c/1jxao1Hx52J-…

Alliance for Clinical Trials in Oncology (@alliance_org) 's Twitter Profile Photo

For #TrialTuesday, .Eric Miller The James leads Alliance for Clinical Trials in Oncology A022101/ERASur, a metastatic #colorectalcancer trial that compares total ablative therapy & usual systemic therapy to usual systemic therapy alone: bit.ly/Alliance-A0221… #NCI #NCTN .Fight Colorectal Cancer .Colorectal Cancer Alliance

For #TrialTuesday, .<a href="/EricMillerMDPhD/">Eric Miller</a> <a href="/OSUCCC_James/">The James</a> leads <a href="/ALLIANCE_org/">Alliance for Clinical Trials in Oncology</a> A022101/ERASur, a metastatic #colorectalcancer trial that compares total ablative therapy &amp; usual systemic therapy to usual systemic therapy alone: bit.ly/Alliance-A0221… #NCI #NCTN .<a href="/FightCRC/">Fight Colorectal Cancer</a> .<a href="/CCAlliance/">Colorectal Cancer Alliance</a>
Fight Colorectal Cancer (@fightcrc) 's Twitter Profile Photo

What if Stage IV colorectal cancer could be treated with curative intent? The ERASur trial is testing total ablative therapy—surgery, radiation, and ablation—for people with oligometastatic disease. This could be a game-changer. šŸ’™ #ASCO25 #ERASur šŸ”—: meetings.asco.org/abstracts-pres…

ECOG-ACRIN Cancer Research Group (@eaonc) 's Twitter Profile Photo

#ClinicalTrial EA2222/PUMP, led by Michael Lidsky, MD, FACS, is a randomized phase 3 study of #SystemicTherapy with or without hepatic arterial infusion for unresectable #Colorectal liver metastases. More here: bit.ly/ea2222-pump cc: Michael D’Angelica, Shishir K. Maithel, Andrea Cercek

#ClinicalTrial EA2222/PUMP, led by <a href="/michael_lidsky/">Michael Lidsky, MD, FACS</a>, is a randomized phase 3  study of #SystemicTherapy with or without hepatic arterial infusion for unresectable #Colorectal liver metastases. More here: bit.ly/ea2222-pump cc: <a href="/MichaelDAngeli2/">Michael D’Angelica</a>, <a href="/skmaithel/">Shishir K. Maithel</a>, <a href="/AndreaCercek/">Andrea Cercek</a>
Alliance for Clinical Trials in Oncology (@alliance_org) 's Twitter Profile Photo

#DYK #ERASur led by Eric Miller The James is testing whether adding targeted treatments like surgery, radiation or heat therapy to standard chemo can help people w/metastatic #colorectalcancer live longer: bit.ly/Alliance-A0221… Fight Colorectal Cancer @ColorectalCAN Colon Cancer Coalition

#DYK #ERASur led by <a href="/EricMillerMDPhD/">Eric Miller</a> <a href="/OSUCCC_James/">The James</a> is testing whether adding targeted treatments like surgery, radiation or heat therapy to standard chemo can help people w/metastatic #colorectalcancer live longer: bit.ly/Alliance-A0221… <a href="/FightCRC/">Fight Colorectal Cancer</a> @ColorectalCAN <a href="/ColonCancerCoal/">Colon Cancer Coalition</a>